No Longer Accepting Cases

September 3, 2013 — The Australian Therapeutic Goods Administration (TGA) has issued a hazard alert to cardiologists and surgeons about the risk of battery depletion on some defibrillators manufactured by Boston Scientific.

This warning includes the Cognis Cardiac Resynchronisation Therapy Defibrillators (CRT-Ds) and Teligen Implantable Cardioverter Defibrillators (ICDs).

Device and model numbers affected include:

  • Cognis CRT-D: N106, N107, N118, N119, P106 and P107
  • Teligen DR ICD: E110 and F110
  • Teligen VR ICD: E102 and F102

Implantable Cardioverter Defibrillators (ICDs) are implantable medical devices that use small electrical currents to treat abnormal heart rhythms. They also coordinate heart beats in the left and right ventricles to improve the heart’s pumping ability. Only defibrillators manufactured before December 2009 are affected by the problem.

Some of the same models of have been linked to reports of malfunction, including at least one death. In April 2007, the U.S. Food and Drug Administration (FDA) issued a Boston Scientific Defibrillator Recall for approximately 73,000 ICDs and CRT-Ds due to the risk of battery depletion. In March 2010, the FDA warned that Boston Scientific had stopped shipment and started recalling all of their ICD and CRT-Ds that have not been implanted.

Meet Your Attorney

Collen A. Clark

Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.

“Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”

To contact Collen, please fill out the contact form below:

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 879-3040.
  • This field is for validation purposes and should be left unchanged.